Semuloparin for use as antithrombotic treatment in Hip replacement Surgery decreased The Incidence of clinically relevant bleeding and major bleeding

摘要

Use of semuloparin or one of its pharmaceutically acceptable salts as antithrombotic treatment in patients suffering from Hip replacement surgery, where such use involves a decreased incidence in terms of clinically significant bleeding and bleeding mayore S.